As with all fields, biopharma goes through its share of trends and fads, and investors who can position themselves properly ahead of time tend to make the most money. But, as is true with all hype cycles, many opportunities carry a significant amount of risk, and there are bound to be a few duds mixed in with the winners.

Let's explore each of the most important biopharma trends of the coming year -- starting with the most investable, and ending with the riskiest -- so that you'll know where to look for opportunities that are right for you.

When it comes to common afflictions in the U.S., there aren't too many that are more prevalent than being overweight. Similarly, diabetes is a major population-level burden, with nearly 12% of Americans affected.

Continue reading

Source Fool.com